Literature DB >> 26965587

Patterns of lymphatic spread and the management of eyelid carcinomas.

Kazuki Hashimoto1, Ryuji Yasumatsu2, Satoshi Toh2, Hideki Shiratsuchi2, Takamasa Yoshida2, Kazuo Nishiyama2, Hiroshi Yoshikawa3, Torahiko Nakashima2, Takashi Nakagawa2.   

Abstract

OBJECTIVE: Eyelid carcinomas are rare, and the management strategy of regional lymph node metastasis linked to eyelid carcinomas has not been standardized to date. The aim of the present study was to analyze the patterns of regional metastasis and to assess the optimal extent of surgical treatment for lymph node metastasis of eyelid carcinoma.
METHODS: This study was a retrospective review of patient data from a single institution. From a series of 268 eyelid carcinomas, we selected the 21 patients with lymph node metastasis, and we analyzed the patterns of lymphatic spread, approach to treatment and outcomes.
RESULTS: The most common histological type of eyelid carcinoma with regional metastasis was sebaceous carcinoma (17/21, 81.0%). Submandibular area metastases were seen only in the patients with the primary tumor originating in the medial half of the eyelid, but parotid area metastases were seen in both the patients whose tumors had a medial-half origin and those with a lateral-half origin. Although 11 of the 16 patients with parotid-area metastases underwent a tumorectomy or superficial parotidectomy (which resulted in four cases of recurrence in the parotid area), none of the five patients who underwent a total parotidectomy developed parotid-area recurrence. The incidence of regional recurrence of the patients who received adjuvant radiotherapy (14.3%) was lower than that of the patients without adjuvant radiotherapy (57.1%).
CONCLUSION: Continued surveillance and optimal management of regional lymph node metastases are important for the control and survival of eyelid carcinomas.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Eyelid carcinoma; Lymph node metastasis; Sebaceous carcinoma; Squamous cell carcinoma; Therapeutic management

Mesh:

Year:  2016        PMID: 26965587     DOI: 10.1016/j.anl.2016.02.011

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  3 in total

1.  Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.

Authors:  Yun Hsia; Ching-Yuan Yeh; Yi-Hsuan Wei; Lily-Wei Chen; Shu-Lang Liao
Journal:  Eye (Lond)       Date:  2019-05-31       Impact factor: 3.775

2.  Endocrine Mucin Producing Sweat Gland Carcinoma with Metastasis to Parotid Gland: Not as Indolent as Perceived?

Authors:  Jayati Sarangi; Abhilash Konkimalla; Kavneet Kaur; Kapil Sikka; Seema Sen; Aanchal Kakkar
Journal:  Head Neck Pathol       Date:  2021-06-28

3.  Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Authors:  Tiina Leivo; Johanna Sarmela; Maria Enckell-Aaltonen; Eva Dafgård Kopp; Caroline Schmitt; Peter B Toft; Haraldur Sigurdsson; Marita Uusitalo
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.